Abstract

The protective effect of selenium against colorectal cancer or adenoma is still a controversial issue. Although there are well-described (pato)physiological protective mechanisms of selenium against colorectal cancer, the results of the studies from 1998-2018 are inconclusive and need to be considered in the future. Neither observational nor experimental studies present consistent results. Although the Cochrane review showed that well-designed randomized clinical trials (RCTs) presented no beneficial effect of selenium supplementation on cancer incidence, well-designed RCTs confirming the protective effect of selenium supplementation against colorectal adenoma or colorectal polyp recurrence have been found in subject-related literature. In the reviewed studies, selenium concentration was measured in the blood serum/toenail or in diet. It is of great importance to highlight that blood selenium concentration depends on the concentration of this micronutrient in food, which in turn depends on selenium content in soil, bioavailability of selenium, which is different in various geographical regions, and forms of selenium. Selenium circulating in blood as a component of selenoproteins participates in oxidoreduction, thus reducing the risk of developing colorectal cancer. Despite this well-known protective mechanism against colorectal cancer occurrence, half of the reviewed studies did not confirm the protective properties of selenium. To sum up, the current state of knowledge on the association between selenium and colorectal cancer or adenoma has revealed not only inconclusive results of the studies, but has also shown that there is a need to conduct more prospective studies focused on selenium supplementation and colorectal cancer as this research is limited.

References

• 1. Avery J.C., Hoffmann P.R.: Selenium, selenoproteins, and immunity.Nutrients, 2018; 10: 1203
  Google Scholar
• 2. Bjelakovic G., Nikolova D., Simonetti R.G., Gluud C.: Systematicreview: Primary and secondary prevention of gastrointestinalcancers with antioxidant supplements. Aliment. Pharmacol. Ther.,2008; 28: 689–703
  Google Scholar
• 3. Bonelli L., Puntoni M., Gatteschi B., Massa P., Missale G., MunizziF., Turbino L., Villanacci V., De Censi A., Bruzzi P.: Antioxidant supplementand long-term reduction of recurrent adenomas of thelarge bowel. A double-blind randomized trial. J. Gastroenterol., 2013;48: 698–705
  Google Scholar
• 4. Borawska M.H., Witkowska A.M., Hukałowicz K., Markiewicz R.:Influence of dietary habits on serum selenium concentration. Ann.Nutr. Metab., 2004; 48: 134–140
  Google Scholar
• 5. Cai X., Wang C., Yu W., Fan W., Wang S., Shen N., Wu P., Li X., WangF.: Selenium exposure and cancer risk: An updated meta-analysis andmeta-regression. Sci. Rep., 2016; 6: 19213
  Google Scholar
• 6. Connelly-Frost A., Poole C., Satia J.A., Kupper L.L., Millikan R.C.,Sandler R.S.: Selenium, folate, and colon cancer. Nutr. Cancer, 2009;61: 165–178
  Google Scholar
• 7. Duffield-Lillico A.J., Reid M.E., Turnbull B.W., Combs G.F. Jr., SlateE.H., Fischbach L.A., Marshall J.R., Clark L.C.: Baseline characteristicsand the effect of selenium supplementation on cancer incidence ina randomized clinical trial: A summary report of the NutritionalPrevention of Cancer Trial. Cancer Epidemiol. Biomarkers Prev.,2002; 11: 630–639
  Google Scholar
• 8. Fernández-Bañares F., Cabré E., Esteve M., Mingorance M.D.,Abad-Lacruz A., Lachica M., Gil A., Gassull M.A.: Serum seleniumand risk of large size colorectal adenomas in a geographical areawith a low selenium status. Am. J. Gastroenterol., 2002; 97: 2103–2108
  Google Scholar
• 9. Food and Agriculture Organization of the United Nations (FAO),World Health Organization (WHO): Chapter 15: Selenium. In: HumanVitamin and Mineral Requirements : Report of a joint FAO/WHO expert consultation, Bangkok, Thailand. Food and NutritionDivision FAO Rome, 2001, 235–250 http://www.fao.org/3/a-y2809e.pdf (28.03.2019)
  Google Scholar
• 10. Ghadirian P., Maisonneuve P., Perret C., Kennedy G., BoyleP., Krewski D., Lacroix A.: A case-control study of toenail seleniumand cancer of the breast, colon, and prostate. Cancer Detect. Prev.,2000; 24: 305–313
  Google Scholar
• 11. Globocan. World Health Organization, International Agencyfor Research on Cancer, Global Cancer Observatory: All cancersfact sheet. http://gco.iarc.fr/today/data/factsheets/cancers/39-All-cancers-fact-sheet.pdf (03.07.2019)
  Google Scholar
• 12. Hansen R.D., Albieri V., Tjønneland A., Overvad K., AndersenK.K., Raaschou-Nielsen O.: Effects of smoking and antioxidant micronutrientson risk of colorectal cancer. Clin. Gastroenterol. Hepatol.,2013; 11: 406–415
  Google Scholar
• 13. Hofstad B., Almendingen K., Vatn M., Andersen S.N., Owen R.W.,Larsen S., Osnes M.: Growth and recurrence of colorectal polyps: Adouble-blind 3-year intervention with calcium and antioxidants.Digestion, 1998; 59: 148–156
  Google Scholar
• 14. Hughes D.J., Fedirko V., Jenab M., Schomburg L., Méplan C., FreislingH., Bueno-de-Mesquita H.B., Hybsier S., Becker N.P., Czuban M.,Tjønneland A., Outzen M., Boutron-Ruault M.C., Racine A., BastideN., et al.: Selenium status is associated with colorectal cancer riskin the European prospective investigation of cancer and nutritioncohort. Int. J. Cancer, 2015; 136: 1149–1161
  Google Scholar
• 15. Jabłońska E., Gromadzińska J., Sobala W., Reszka E., WąsowiczW.: Lung cancer risk associated with selenium status is modifiedin smoking individuals by Sep15 polymorphism. Eur. J. Nutr., 2008;47: 47–54
  Google Scholar
• 16. Jacobs E.T., Jiang R., Alberts D.S., Greenberg E.R., GunterE.W., Karagas M.R., Lanza E., Ratnasinghe L., Reid M.E., SchatzkinA., Smith-Warner S.A., Wallace K., Martínez M.E.: Selenium andcolorectal adenoma: Results of a pooled analysis. J. Natl. CancerInst., 2004; 96: 1669–1675
  Google Scholar
• 17. Jaworska K., Jakubowska A., Lubiński J.: Chemoprewencja selenem(Se) w rakach tytoniozależnych. W: Genetyka kliniczna nowotworów2011, ed.: J. Lubiński, Szczecin Print Group, Szczecin 2011,277–288
  Google Scholar
• 18. Kune G., Watson L.: Colorectal cancer protective effects and thedietary micronutrients folate, methionine, vitamins B6, B12, C, E,selenium, and lycopene. Nutr. Cancer, 2006; 56: 11–21
  Google Scholar
• 19. Laclaustra M., Stranges S., Navas-Acien A., Ordovas J.M., GuallarE.: Serum selenium and serum lipids in US adults: National Healthand Nutrition Examination Survey (NHANES) 2003–2004. Atherosclerosis,2010; 210: 643–648
  Google Scholar
• 20. Lener M.R., Gupta S., Scott R.J., Tootsi M., Kulp M., TammesooM.L., Viitak A., Metspalu A., Serrano-Fernández P., Kładny J., Jaworska-Bieniek K., Durda K., Muszyńska M., Sukiennicki G., JakubowskaA., Lubiński J.: Can selenium levels act as a marker of colorectal cancerrisk? BMC Cancer, 2013; 13: 214
  Google Scholar
• 21. Lener M., Jaworska-Bieniek K., Muszyńska M., Sukiennicki G.,Durda K., Gromowski T., Marciniak W., Serrano-Fernández P., KładnyJ., Wiechowska-Kozłowska A., Grodzki T., Jaworowska E., LubińskiJ., Górecka-Szyld B., Wilk G., et al.: Selen i rak. Opracowanie własne(read-gene) do celów naukowo-edukacyjnych. http://www.readgene.com/files/ckfinder/file/Selen%20i%20rak.pdf (04.09.2019)
  Google Scholar
• 22. Lener M., Muszyńska M., Jakubowska A., Jaworska-BieniekK., Sukiennicki G., Kaczmarek K., Durda K., Gromowski T., Serrano-Fernández P., Kładny J., Wiechowska-Kozłowska A., Grodzki T.,Jaworowska E., Lubiński J., Górecka-Szyld B., et al.: Selenium as amarker of cancer risk and of selection for control examinations insurveillance. Contemp. Oncol., 2015; 19: A60–A61
  Google Scholar
• 23. Lippman S.M., Klein E.A., Goodman P.J., Lucia M.S., ThompsonI.M., Ford L.G., Parnes H.L., Minasian L.M., Gaziano J.M., Hartline J.A.,Parsons J.K., Bearden J.D. 3rd, Crawford E.D., Goodman G.E., ClaudioJ., et al.: Effect of selenium and vitamin E on risk of prostate cancerand other cancers: The Selenium and Vitamin E Cancer PreventionTrial (SELECT). J. Am. Med. Assoc., 2009; 301: 39–51
  Google Scholar
• 24. Markiewicz-Żukowska R.: Selen w żywności. XVI Sympozjum„Środowisko – zdrowie – żywność”, MS Spektrum, Ślesin, 17-19.05.2010. Wykład. https://www.msspektrum.pl/sympozja/pdfy/slesin2010_borawska_markiewicz_zukowska2.pdf (01.10.2019)
  Google Scholar
• 25. Niedzielski P., Siepak M., Siepak J.: Występowanie i zawartości arsenu,antymonu i selenu w wodach i innych elementach środowiska.Rocz. Ochr. Środowiska, 2000; 2: 317–341
  Google Scholar
• 26. Pais R., Dumitraşcu D.L.: Do antioxidants prevent colorectalcancer? A meta-analysis. Rom. J. Intern. Med., 2013; 51: 152–163
  Google Scholar
• 27. Peters U., Chatterjee N., Church T.R., Mayo C., Sturup S., FosterC.B., Schatzkin A., Hayes R.B.: High serum selenium and reduced riskof advanced colorectal adenoma in a colorectal cancer early detectionprogram. Cancer Epidemiol. Biomarkers Prev., 2006; 15: 315–320
  Google Scholar
• 28. Psathakis D., Wedemeyer N., Oevermann E., Krug F., Siegers C.P.,Bruch H.P.: Blood selenium and glutathione peroxidase status in patientswith colorectal cancer. Dis. Colon Rectum, 1998; 41: 328–335
  Google Scholar
• 29. Ratajczak M., Gietka-Czernel M.: Rola selenu w organizmieczłowieka. Post. Nauk. Med., 2016; 29: 929–933
  Google Scholar
• 30. Rayman M.P.: Selenium and human health. Lancet, 2012; 379:1256–1268
  Google Scholar
• 31. Takata Y., Kristal A.R., King I.B., Song X., Diamond A.M., FosterC.B., Hutter C.M., Hsu L., Duggan D.J., Langer R.D., PetrovitchH., Shikany J.M., Vaughan T.L., Lampe J.W., Prentice R.L., PetersU.: Serum selenium, genetic variation in selenoenzymes, and riskof colorectal cancer: Primary analysis from the Women’s HealthInitiative (WHI) Observational Study and meta-analysis. CancerEpidemiol. Biomarkers Prev., 2011; 20: 1822-1830
  Google Scholar
• 32. Thompson P.A., Ashbeck E.L., Roe D.J., Fales L., Buckmeier J.,Wang F., Bhattacharyya A., Hsu C.H., Chow H.H., Ahnen D.J., BolandC.R., Heigh R.I., Fay D.E., Hamilton S.R., Jacobs E.T., Martinez M.E.,Alberts D.S., Lance P.: Selenium supplementation for preventionof colorectal adenomas and risk of associated type 2 diabetes. J.Natl. Cancer Inst., 2016; 108: djw152
  Google Scholar
• 33. Thorling E.B., Overvad K., Geboers J.: Selenium status in Europe– human data. A multicenter study. Ann. Clin. Res., 1986; 18: 3–7
  Google Scholar
• 34. U.S. Department of Agriculture, Agricultural Research Service:USDA National Nutrient Database for Standard Reference, Release25, 2012 http://www.ars.usda.gov/ARSUserFiles/80400525/Data/SR25/sr25_doc.pdf (04.04.2019)
  Google Scholar
• 35. Vinceti M., Filippini T., Del Giovane C., Dennert G., Zwahlen M.,Brinkman M., Zeegers M.P., Horneber M., D’Amico R., Crespi C.M.:Selenium for preventing cancer. Cochrane Database Syst. Rev., 2018;1: CD005195
  Google Scholar
• 36. Wallace K., Byers T., Morris J.S., Cole B.F., Greenberg E.R., BaronJ.A., Gudino A., Spate V., Karagas M.R.: Prediagnostic serum seleniumconcentration and the risk of recurrent colorectal adenoma:A nested case-control study. Cancer Epidemiol. Biomarkers Prev.,2003; 12: 464–467
  Google Scholar
• 37. Wąsowicz W., Zachara B.A.: Selenium concentrations in theblood and urine of a healthy Polish sub-population. J. Clin. Chem.Clin. Biochem., 1987; 25: 409–412
  Google Scholar
• 38. Williams C.D., Satia J.A., Adair L.S., Stevens J., Galanko J., KekuT.O., Sandler R.S.: Antioxidant and DNA methylation-related nutrientsand risk of distal colorectal cancer. Cancer Causes Control,2010; 21: 1171–1181
  Google Scholar
• 39. Yang B., McCullough M.L., Gapstur S.M., Jacobs E.J., BostickR.M., Fedirko V., Flanders W.D., Campbell P.T.: Calcium, vitamin D,dairy products, and mortality among colorectal cancer survivors:The Cancer Prevention Study-II Nutrition Cohort. J. Clin. Oncol.,2014; 32: 2335–2343
  Google Scholar

Full text